Literature DB >> 25797076

Fisher Grading Scale Associated with Language Disorders in Patients with Anterior Circulation Aneurysmal Subarachnoid Hemorrhage.

Moysés Loiola Ponte de Souza1, Ana Cláudia C Vieira2, Gustavo Andrade3, Saul Quinino4, Maria de Fátima Leal Griz5, Hildo R C Azevedo-Filho4.   

Abstract

OBJECTIVE: To associate the presence of language deficits with varying scores of the Fisher grading scale in patients with subarachnoid hemorrhage in the period preceding the treatment of aneurysm in the anterior circulation, as well as to compare the scores of this scale, identifying the grades more associated with the decline of language.
METHODS: Database analysis of 185 preoperative evaluations of language, through the Montreal Toulouse Protocol Alpha version and verbal fluency through CERAD battery, of patients from "Hospital da Restauração" with aneurysmal subarachnoid hemorrhage, divided according to the Fisher grading scale (Fisher I, II, III, or IV) and compared with a control group of individuals considered normal.
RESULTS: The various scores of the Fisher grading scale have different levels of language deficits, more pronounced as the amount of blood increases. Fisher III and IV scores are most associated with the decline of language.
CONCLUSIONS: Our study made it possible to obtain information not yet available in the literature, by correlating the various scores of the Fisher grading scale with language yet in the period preceding treatment.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Computed tomography; Fisher scale; Intracranial aneurysm; Neuropsychological assessment; Subarachnoid hemorrhage

Mesh:

Year:  2015        PMID: 25797076     DOI: 10.1016/j.wneu.2015.03.017

Source DB:  PubMed          Journal:  World Neurosurg        ISSN: 1878-8750            Impact factor:   2.104


  1 in total

1.  The neuropsychological assessment battery (NAB) is a valuable tool for evaluating neuropsychological outcome after aneurysmatic subarachnoid hemorrhage.

Authors:  Johannes Walter; Martin Grutza; Lidia Vogt; Andreas Unterberg; Klaus Zweckberger
Journal:  BMC Neurol       Date:  2020-11-26       Impact factor: 2.474

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.